SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
SEC Accession No. 0001209191-20-020219
Filing Date
2020-03-19
Accepted
2020-03-19 13:26:12
Documents
1
Period of Report
2020-02-12

Document Format Files

Seq Description Document Type Size
1 FORM 4/A SUBMISSION doc4a.html 4/A  
1 FORM 4/A SUBMISSION doc4a.xml 4/A 3370
  Complete submission text file 0001209191-20-020219.txt   4768
Mailing Address 8201 E. RIVERSIDE DRIVE BUILDING 4, SUITE 100 AUSTIN TX 78744
Business Address 8201 E. RIVERSIDE DRIVE BUILDING 4, SUITE 100 AUSTIN TX 78744 512-386-2930
XBiotech Inc. (Issuer) CIK: 0001626878 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 77 KING STREET WEST SUITE 3000 TORONTO A6 M5K 1G8
Business Address
Waldin Jan-Paul (Reporting) CIK: 0001733176 (see all company filings)

Type: 4/A | Act: 34 | File No.: 001-37347 | Film No.: 20727601